Series A brings in $42mm for Dermira
Executive Summary
Dermira Inc. (dermatology therapeutics) has raised $42mm through its Series A venture round. Bay City Capital led and was joined by New Enterprise Associates and Canaan Partners. Each firm will contribute one board member.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice